Unraveling the Systems Biology of Curcumin: A Mini-review of its Anti-diabetic Potential through Network Pharmacology.

Diabetes mellitus (DM) is a complex metabolic disease marked by persistent hyperglycemia and a range of related complications, stemming from intricate molecular mechanisms such as oxidative stress, chronic inflammation, and disrupted insulin signaling pathways. Current treatments typically target a single molecule, which limits their effectiveness against the complex, interconnected pathways of DM. Curcumin, a naturally occurring polyphenolic compound extracted from Curcuma longa, has emerged as a promising candidate due to its wide-ranging biological activities and ability to influence multiple molecular pathways involved in DM progression. This mini-review employs a systems biology and network pharmacology approach to explore the diverse molecular targets and key signaling cascades modulated by curcumin, including the AGE-RAGE, PI3K-Akt, TNF, and JAK-STAT pathways. By integrating computational predictions with findings from laboratory and clinical studies, we provide insights into curcumin’s ability to reduce oxidative stress, suppress inflammation, and enhance insulin sensitivity through its multi-targeted actions. Additionally, we discuss the therapeutic relevance of these mechanisms in improving blood glucose regulation and minimizing DM complications, as evidenced by outcomes from clinical investigations. The review also addresses curcumin’s low bioavailability and highlights the emerging role of nano-formulation techniques in enhancing its pharmacokinetic properties. Finally, we identify key gaps in the current research landscape and emphasize the need for comprehensive clinical trials that reflect curcumin’s complex pharmacological profile. Overall, this systems-based evaluation supports curcumin’s potential as a valuable multi-target therapeutic agent that could complement current DM treatments and contribute to better patient care.